Integra LifeSciences Fair Value Call Sees 73% Gain in 12 Months

Integra LifeSciences reported a 73% gain in its fair value over the past 12 months following their recent call. The increase showcases strong performance and suggests robust business growth. This gain could influence investor confidence and market perception of the company. For investors, this performance metric indicates potential opportunities in Integra LifeSciences (IART).